Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Investigators at Duke University Report Findings in Tumor Necrosis Factors (Cd40 Ligand Antagonist Dazodalibep In Sjogren's Disease: a Randomized, Double-blinded, Placebo-controlled, Phase 2 Trial)
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Source:Medical Letter on the CDC & FDA. July 21, 2024, 673
No Comments.